DF/HCC ETCTN Investigators

Jon E. Arnason, MD

Beth Israel Deaconess Medical Center

David J. Kwiatkowski, MD, PhD

Brigham and Women’s Hospital

Isabel C. Arrillaga-Romany, MD, PhD

Massachusetts General Hospital

Nicole LeBoeuf, MD

Brigham and Women’s Hospital

Edwin Choy, MD, PhD

Massachusetts General Hospital

Joyce Liu, MD, MPH

Dana-Farber Cancer Institute
James Cleary, MD, PhD
Dana-Farber Cancer Institute 

Marlise Luskin, MD

Dana-Farber Cancer Institute

Atish Choudhury, MD, PhD

Dana-Farber Cancer Institute 

Priscilla Merriam, MD

Dana-Farber Cancer Institute

Ryan B. Corcoran, MD, PhD

Massachusetts General Hospital

Myrna Nahas, MD

Beth Israel Deaconess Medical Center

Matthew S. Davids, MD

Dana-Farber Cancer Institute

Lakshmi Nayak, MD

Dana-Farber Cancer Institute

Khanh Do, MD

Dana-Farber Cancer Institute

Patrick Ott, MD, PhD

Dana-Farber Cancer Institute

Anna F. Farago, MD, PhD

Massachusetts General Hospital

Geoffrey Oxnard, MD

Dana-Farber Cancer Institute

Jacqueline S. Garcia, MD

Dana-Farber Cancer Institute

Jacob Sands, MD

Dana-Farber Cancer Institute

Suzanne George, MD

Dana-Farber Cancer Institute

Philip J. Saylor, MD

Massachusetts General Hospital

Lipika Goyal, MD

Massachusetts General Hospital

Jonathan D. Schoenfeld, MD, MPH

Brigham and Women’s Hospital

F. Stephen Hodi, MD

Dana-Farber Cancer Institute

Geoffrey I. Shapiro, MD, PhD

Dana-Farber Cancer Institute

Caron A. Jacobson, MD

Dana-Farber Cancer Institute

Ryan J. Sullivan, MD

Massachusetts General Hospital

Pasi Janne, MD, PhD

Dana-Farber Cancer Institute

Mary-Ellen Taplin, MD

Dana-Farber Cancer Institute

Panagiotis A. Konstantinopoulos, MD, PhD

Dana-Farber Cancer Institute

Gerburg Wulf, MD, PhD

Beth Israel Deaconess Medical Center